Literature DB >> 33419086

The Optimizing Background Infusion Mode Decreases Intravenous Patient-Controlled Analgesic Volume and Opioid Consumption Compared to Fixed-Rate Background Infusion in Patients Undergoing Laparoscopic Cholecystectomy: A Prospective, Randomized, Controlled, Double-Blind Study.

Ki Tae Jung1,2, Keum Young So1,2, Seung Un Kim2, Sang Hun Kim1,2.   

Abstract

Background and objectives: The fixed-rate continuous background infusion mode with bolus dosing is a common modality for intravenous patient-controlled analgesia (PCA). However, some patients suffer from inadequate analgesia or opioid-related adverse effects due to the biphasic pattern of postoperative pain. Therefore, we investigated the postoperative analgesic efficacy of PCA using an optimizing background infusion mode (OBIM) where the background injection rate varies depending on the patient's bolus demand. Materials and
Methods: We prospectively enrolled 204 patients who underwent laparoscopic cholecystectomy in a randomized, controlled, double-blind study. Patients were allocated to either the optimizing (group OBIM) or the traditional background infusion group (group TBIM). The numeric rating scale (NRS) score for pain was evaluated at admission to and discharge from the recovery room, as well as at the 6th, 24th, and 48th postoperative hours. Data on bolus demand count, total infused volume, and background infusion rate were downloaded from the PCA device at 30-min intervals until the 48th postoperative hour.
Results: The NRS score was not significantly different between groups throughout the postoperative period (p = 0.621), decreasing with time in both groups (p < 0.001). The bolus demand count was not significantly different between groups throughout (p = 0.756). The mean total cumulative infused PCA volume was lower in group OBIM (84.0 (95% confidence interval: 78.9-89.1) mL) than in group TBIM (102 (97.8-106.0) mL; p < 0.001). The total cumulative opioid dose in fentanyl equivalents, after converting sufentanil to fentanyl using an equipotential dose ratio, was lower in group OBIM (714.1 (647.4-780.9) μg) than in group TBIM (963.7 (870.5-1056.9) μg); p < 0.001). The background infusion rate was significantly different between groups throughout the study period (p < 0.001); it was higher in group OBIM than in group TBIM before the 12th postoperative hour and lower from the 18th to the 48th postoperative hour. Conclusions: The OBIM combined with bolus dosing reduces the cumulative PCA volume and opioid consumption compared to the TBIM combined with bolus dosing, while yielding comparable postoperative analgesia and bolus demand in patients undergoing laparoscopic cholecystectomy.

Entities:  

Keywords:  background infusion; intravenous infusions; laparoscopic cholecystectomy; opioid analgesics; patient-controlled analgesia; postoperative pain

Mesh:

Substances:

Year:  2021        PMID: 33419086      PMCID: PMC7825461          DOI: 10.3390/medicina57010042

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  18 in total

1.  Comparison of computer-integrated patient-controlled epidural analgesia and patient-controlled epidural analgesia with a basal infusion for labour and delivery.

Authors:  B L Sng; A T H Sia; Y Lim; D Woo; C Ocampo
Journal:  Anaesth Intensive Care       Date:  2009-01       Impact factor: 1.669

Review 2.  Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain.

Authors:  Ewan D McNicol; McKenzie C Ferguson; Jana Hudcova
Journal:  Cochrane Database Syst Rev       Date:  2015-06-02

3.  Effects of postoperative background PCA morphine infusion on pain management and related side effects in patients undergoing abdominal hysterectomy.

Authors:  Wei-Hung Chen; Kang Liu; Peng-Heng Tan; Yuan-Yi Chia
Journal:  J Clin Anesth       Date:  2011-03       Impact factor: 9.452

4.  Efficacy and complications of patient-controlled analgesia treatment after spinal surgery.

Authors:  Reuven Gepstein; Zeev Arinzon; Yoram Folman; Ishay Shuval; Shay Shabat
Journal:  Surg Neurol       Date:  2007-04

5.  Insufficient pain management after spine surgery.

Authors:  Rikke Vibeke Nielsen; Jonna Storm Fomsgaard; Jørgen Berg Dahl; Ole Mathiesen
Journal:  Dan Med J       Date:  2014-05       Impact factor: 1.240

6.  Computer-integrated patient-controlled epidural analgesia: a preliminary study on a novel approach of providing pain relief in labour.

Authors:  A T Sia; Y Lim; C E Ocampo
Journal:  Singapore Med J       Date:  2006-11       Impact factor: 1.858

7.  Patient-controlled analgesia versus patient-controlled analgesia plus continuous infusion after hip replacement surgery.

Authors:  M A Smythe; M P O'Donnell; R F Schad; C F Dmuchowski
Journal:  Ann Pharmacother       Date:  1996-03       Impact factor: 3.154

8.  Comparison of computer integrated patient controlled epidural analgesia vs. conventional patient controlled epidural analgesia for pain relief in labour.

Authors:  Y Lim; A T Sia; C E Ocampo
Journal:  Anaesthesia       Date:  2006-04       Impact factor: 6.955

9.  Comparison of computer-integrated patient-controlled epidural analgesia with no initial basal infusion versus moderate basal infusion for labor and delivery: A randomized controlled trial.

Authors:  Ban Leong Sng; David Woo; Wan Ling Leong; Hao Wang; Pryseley Nkouibert Assam; Alex Th Sia
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10

10.  A comparison of 2 intravenous patient-controlled analgesia modes after spinal fusion surgery: Constant-rate background infusion versus variable-rate feedback infusion, a randomized controlled trial.

Authors:  Seung Hyuk Lee; Chong Wha Baek; Hyun Kang; Yong-Hee Park; Geun Joo Choi; Yong Hun Jung; Young Cheol Woo
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

View more
  1 in total

Review 1.  Clinical Update on Patient-Controlled Analgesia for Acute Postoperative Pain.

Authors:  Cyrus Motamed
Journal:  Pharmacy (Basel)       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.